To the Editor: It was with great pleasure that we read the review entitled 'Nephrolithiasis-associated bone disease: pathogenesis and treatment options' by Sakhaee et al. 1 Studies on an association between distal renal tubular acidosis (dRTA), calcium nephrolithiasis, and bone histomorphometry are scarce. The authors stated that no studies have been published in which bone histomorphometry and dual-energy X-ray absorptiometry have been used to link bone disease with dRTA. This is not correct, because in this very jounal, Domrongkitchaiporn et al. 2, 3 published a series of small studies from Thailand-where the incidence of dRTA is very high-on bone histology and bone mineral density before and after correction of acidosis in dRTA patients. They demonstrated that low bone mass levels, suppressed bone formation rates, and osteoblastic and osteoclastic activity were common findings in such patients. Correction of chronic metabolic acidosis with alkaline therapy resulted in a marked increase in bone formation. A further study from the same group showed different degrees of impaired bone matrix mineralization in dRTA patients and that alkaline therapy increased bone mass through the restoration of bone mineral balance. 4 The Author Replies: Arampatzis et al.
1 raise an important point regarding our article entitled 'Nephrolithiasisassociated bone disease: pathogenesis and treatment options'.
2 I agree that short-term studies conducted in a small number of patients have shown alkali treatment to be effective in patients with distal renal tubular acidosis (dRTA). [3] [4] [5] However, two studies cited by Arampatzis et al. showed bone mineral density (BMD) Z-scores at the L 2 -L 4 spine (À0. 46±1.21 (ref. 3) and À0.4±1.2 (ref. 4) ) were within normal ranges. Moreover, Z-score at the total femur, femoral neck, Ward's triangle, and trochanter were all normal. 3, 4 On the basis of mean age of these populations (32.7 ± 11.9 (ref.
3) and 31.6 ± 11.1 (ref. 4) ), the diagnosis of osteopenia/osteoporosis would be more reliable on the basis of Z-score as opposed to T-score, which is an inaccurate way to assess BMD in a population of this age. Nonetheless, in one study using T-scores, even BMD at the L 2 -L 4 spine was barely below normal, with a T-score of À1.24±1.46. Moreover, T-score at the total femur (À0.36±1.32) and femoral neck (À0.55 ± 1.64), two common sites for assessment of bone loss, were both within normal ranges. Only the Ward's triangle, an uncommon site for the diagnosis of osteopenia/osteoporosis, was osteopenic, with a T-score of À1.56±1.51. 3 As noted, evidence of normal BMD excludes the possibility of impaired bone mass. This is the reason we indicated that there are no studies linking bone disease with dRTA and kidney stones.
